Firma TissUse, Autor bei PR-Web

TissUse reports progress made in collaboration with AstraZeneca to use Microphysiological Systems in the drug development process

Posted on 22. January 201811. December 2019 by Firma TissUse Posted in Research / Development Tagged biotech, cell, chemicals, danielson, diabetes, disease, imed, insulin, mps, new, patients, study, testing, tissuse, with

TissUse continues their successful collaboration with AstraZeneca to establish relevant Microphysiological System (MPS) models based on TissUse’s Multi-Organ-Chip technology. As part of the collaboration, the teams have explored the unmet need for a physiologically relevant human ex-vivo type 2 diabetes […]